Neutropenia and off-label use: case report

    This is a preview of subscription content, access via your institution.


    1. Campochiaro C, et al. Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study. Rheumatology 59: 3731-3736, No. 12, Dec 2020. Available from: URL:

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Methotrexate/rituximab. Reactions Weekly 1843, 237 (2021).

    Download citation